Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M700644200 on May 9, 2007

J. Biol. Chem., Vol. 282, Issue 26, 19092-19102, June 29, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/26/19092    most recent
M700644200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baldock, P. A.
Right arrow Articles by Herzog, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baldock, P. A.
Right arrow Articles by Herzog, H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Novel Role of Y1 Receptors in the Coordinated Regulation of Bone and Energy Homeostasis*

Paul A. Baldock{ddagger}1, Susan J. Allison{ddagger}12, Pernilla Lundberg§, Nicola J. Lee§, Katy Slack§, En-Ju D. Lin§, Ronaldo F. Enriquez{ddagger}, Michelle M. McDonald||, Lei Zhang§, Matthew J. During**, David G. Little||, John A. Eisman{ddagger}, Edith M. Gardiner{ddagger}{ddagger}3, Ernie Yulyaningsih§, Shu Lin§, Amanda Sainsbury§4, and Herbert Herzog§45

From the {ddagger}Bone and Mineral Program and §Neuroscience Research Program, Garvan Institute of Medical Research, St Vincent's Hospital, 384 Victoria St, Darlinghurst, Sydney, New South Wales 2010, the Department of Oral Cell Biology, Umeå University, Umeå S-901 87, Sweden, the ||Department of Orthopaedic Research & Biotechnology, The Children's Hospital at Westmead, Sydney 2000, Australia, the **Department of Molecular Medicine & Pathology, University of Auckland, Auckland 1001, New Zealand, and the {ddagger}{ddagger}Diamantina Institute, University of Queensland, Princess Alexandra Hospital, Brisbane, Queensland 4102, Australia

The importance of neuropeptide Y (NPY) and Y2 receptors in the regulation of bone and energy homeostasis has recently been demonstrated. However, the contributions of the other Y receptors are less clear. Here we show that Y1 receptors are expressed on osteoblastic cells. Moreover, bone and adipose tissue mass are elevated in Y1-/- mice with a generalized increase in bone formation on cortical and cancellous surfaces. Importantly, the inhibitory effects of NPY on bone marrow stromal cells in vitro are absent in cells derived from Y1-/- mice, indicating a direct action of NPY on bone cells via this Y receptor. Interestingly, in contrast to Y2 receptor or germ line Y1 receptor deletion, conditional deletion of hypothalamic Y1 receptors in adult mice did not alter bone homeostasis, food intake, or adiposity. Furthermore, deletion of both Y1 and Y2 receptors did not produce additive effects in bone or adiposity. Thus Y1 receptor pathways act powerfully to inhibit bone production and adiposity by nonhypothalamic pathways, with potentially direct effects on bone tissue through a single pathway with Y2 receptors.


Received for publication, January 23, 2007 , and in revised form, April 19, 2007.

* This work was supported by the National Health and Medical Research Council (NHMRC, Grant 376021 to H. H. and Grant 230820 to A. S.), by an NHMRC Fellowship (188827) and the Diabetes Australia Research Trust (to A. S.), by an NHMRC scholarship (to S. J. A.), an NHMRC Fellowship (to H. H.), by a Swedish Society for Medical Research fellowship (to P. L.), and by the Swedish Research Council for Medicine. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Both authors contributed equally to this work.

2 Present address: Laboratory of Neural Stem Cell Biology, Stem Cell Institute, University Hospital, Lund 22184, Sweden.

3 Present address: School of Medicine, University of Queensland, Brisbane 4000, Queensland, Australia.

4 Both authors contributed equally to this work.

5 To whom correspondence should be addressed: Tel.: 61-2-9295-8296; Fax: 61-2-9295-8281; E-mail: h.herzog{at}garvan.org.au.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
IBMS BoneKEyHome page
I. Bab and R. Yirmiya
Depression, Selective Serotonin Re-Uptake Inhibitors and the Regulation of Bone Mass
IBMS BoneKEy, January 1, 2009; 6(1): 8 - 15.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement